XML 48 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Event (Details) - Incyte Corporation - Incyte MGA012 Agreement - Subsequent Event
$ in Millions
1 Months Ended
Oct. 31, 2017
USD ($)
Subsequent Event [Line Items]  
Non-refundable upfront payment $ 150.0
Minimum  
Subsequent Event [Line Items]  
Potential royalty revenue percent 15.00%
Maximum  
Subsequent Event [Line Items]  
Potential clinical, regulatory and commercialization milestone payments $ 750.0
Potential royalty revenue percent 24.00%